NEW YORK (GenomeWeb News) – Pacific Biosciences reported after the close of the market Thursday that its third quarter 2014 revenues rose 178 percent year over year and 81 percent sequentially.

The Menlo Park, Calif.-based single-molecule sequencing technologies firm reported Q3 revenues of $20.6 million, compared to $7.4 million in Q3 2013 and $11.4 million in Q2 2014. It beat the consensus Wall Street estimate of $17.2 million in revenues for the quarter.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.